Candesartan Metabolite B |
|
| Synonyms: Candesartan N2-Glucuronide; 1-[5-[4'-[(7-Carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-a-D-glucopyranuronic Acid; | |
| Cat. No.: C16031 | CAS No.: 180603-76-3 |
| MDL.: | Formula: C30H28N6O9 |
| F.W.616.58 | Purity: 99% |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | $215.00 | Enter qty and click checkbox |
 
|
$215.00 |
| Catalog Number： | C16031 | CAS No.: | 180603-76-3 | |
| MDL: | Formula: | C30H28N6O9 | ||
| F.W.: | 616.58 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | No Data Available | |
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Huskey, S., et al.: Drug Metab. Dispos., 21, 792 (1993), Hilditch, A., et al.: Br. J. Pharmacol., 111, 137(1994), Reiss, P., et al.: Bioorg. Med. Chem., 7, 2199 (1999), Soars, M., et al.: J. Pharmacol. Toxicol. Methods, 47, 161 (2002), Soars, M., et al.: J. Pharmacol. Toxicol. Methods, 47, 161 (2002), | |||
| Application: | A metabolite of Candesartan. | |||
| Category: | Glucuronides, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals | |||